Cited by 1,039Cannabis and Cannabinoid ResearchReceptor Mechanisms and SignalingNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor

Open access

Laprairie, R B, Bagher, A M, Kelly, M E M, Denovan‐Wright, E M·2015·British Journal of Pharmacology

DOI 10.1111/bph.13250PMC PMC4621983

Open this paper in CoChat — free account

Abstract

Background and Purpose: Cannabidiol has been reported to act as an antagonist at cannabinoid CB 1 receptors. We hypothesized that cannabidiol would inhibit cannabinoid agonist activity through negative allosteric modulation of CB 1 receptors. Experimental Approach: Internalization of CB 1 receptors, arrestin2 recruitment, and PLCβ3 and ERK1/2 phosphorylation, were quantified in HEK 293A cells heterologously expressing CB 1 receptors and in the ST Hdh Q7/Q7 cell model of striatal neurons endogenously expressing CB 1 receptors. Cells were treated with 2‐arachidonylglycerol or Δ 9 ‐tetrahydrocannabinol alone and in combination with different concentrations of cannabidiol. Key Results: Cannabidiol reduced the efficacy and potency of 2‐arachidonylglycerol and Δ 9 ‐tetrahydrocannabinol on PLCβ3‐ and ERK1/2‐dependent signalling in cells heterologously (HEK 293A) or endogenously (ST Hdh Q7/Q7 ) expressing CB 1 receptors. By reducing arrestin2 recruitment to CB 1 receptors, cannabidiol treatment prevented internalization of these receptors. The allosteric activity of cannabidiol depended upon polar residues being present at positions 98 and 107 in the extracellular amino terminus of the CB 1 receptor. Conclusions and Implications: Cannabidiol behaved as a non‐competitive negative allosteric modulator of CB 1 receptors. Allosteric modulation, in conjunction with effects not mediated by CB 1 receptors, may explain the in vivo effects of cannabidiol. Allosteric modulators of CB 1 receptors have the potential to treat CNS and peripheral disorders while avoiding the adverse effects associated with orthosteric agonism or antagonism of these receptors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/bph.13250

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 934
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Pawson, A. J., Sharman, J. L., Benson, H. E., Faccenda, E., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., Southan, C., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1143 · Cited by 845
Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 763
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
Trettel, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2799 · Cited by 614
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 561
Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
McPartland, J. M., Duncan, M., Marzo, V. D., & Pertwee, R. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12944 · Cited by 552
Cannabidiol—recent advances
Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515

Show all 47 references

Sorted by citations

Items 601–700 of 1,000

Stereoisomers of cannabidiols and their pharmacological activities – A potentially novel direction for cannabinoids
Rao, V. K., Lewis‐Bakker, M. M., Wasilewski, E., Clarke, H. A., & Kotra, L. P. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.118019 · Cited by 11
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor
Billard, É., Torbey, A. G., Inserra, A., Grant, E., Bertazzo, A., Gregorio, D. D., Comai, S., Chatenet, D., Gobbi, G., & Hébert, T. E. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111588 · Cited by 11
The neural and psychophysiological effects of cannabidiol in youth with alcohol use disorder: A randomized controlled clinical trial
Kirkland, A. E., Browning, B. D., Meredith, L. R., Robertson, E. J., Herring, C., Tomko, R. L., Gray, K. M., & Squeglia, L. M. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02141-z · Cited by 11
Serotonin 2A receptors and cannabinoids
Ibarra‐Lecue, I., Dı́ez-Alarcia, R., & Urigüen, L. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.004 · Cited by 11
Cannabidiol-dihydroartemisinin conjugates for ameliorating neuroinflammation with reduced cytotoxicity
Wang, F., Li, M., Lin, C., Jin, S., Li, H., Lu, Y., Wang, H., Wang, H., & Wang, X. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116131 · Cited by 12
Imaging Cannabinoid Receptors: A Brief Collection of Covalent and Fluorescent Probes for CB1 and CB2 Receptors
Hamilton, A. J., Payne, A. D., Mocerino, M., & Gunosewoyo, H. (2021) · Australian Journal of Chemistry · doi:10.1071/ch21007 · Cited by 11
Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived Neurons
Lillo, J., Raïch, I., Silva, L., Zafra, D. A., Lillo, A., Ferreiro‐Vera, C., de Medina, V. S., Martínez-Orgado, J. A., Franco, R., & Navarro, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179695 · Cited by 11
A cannabinoid Hairy‐Tale : Hair loss or hair gain?
Gupta, A. K., & Talukder, M. (2022) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.15427 · Cited by 11
High-CBD Cannabis Vapor Attenuates Opioid Reward and Partially Modulates Nociception in Female Rats
Rivera-Garcia, M. T., Rose, R. M., & Wilson‐Poe, A. R. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100050 · Cited by 11
Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform
Bunsick, D. A., Matsukubo, J., & Szewczuk, M. R. (2023) · Cancers · doi:10.3390/cancers15041030 · Cited by 11
Oral Cannabidiol does not alter Alcohol Seeking and Self‐Administration in Baboons
Moore, C. F., Zamarripa, C. A., & Weerts, E. M. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109829 · Cited by 11
Full spectrum cannabidiol-rich extract reduced propofol dosage required for anesthetic induction in dogs—a pilot study
Gewehr, J. L. H., Enzele, M. L., Freiria, L. M., Nunes, M. M., Spengler, J., Teixeira, A. P. D., Amazonas, E. D. A., & Padilha, V. S. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1352314 · Cited by 11
A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol
Wright, N. J. D. (2024) · AIMS neuroscience · doi:10.3934/neuroscience.2024009 · Cited by 11
Therapeutic potential of CBD in Autism Spectrum Disorder
Pedrazzi, J. F. C., Hassib, L., Ferreira, F. R., Hallak, J. E. C., Del-Bel, E., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.002 · Cited by 12
Cannabis and Cannabinoid Signaling: Research Gaps and Opportunities
Valentino, R. J., & Volkow, N. D. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002331 · Cited by 11
Cannabidiol: A budding industry!
Steenson, S., & Chambers, L. (2019) · Nutrition Bulletin · doi:10.1111/nbu.12395 · Cited by 12
Neuromolecular Mechanisms of Cannabis Action
Adel, Y., & Alexander, S. P. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_2 · Cited by 11
Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group
Hallinan, C. M., Eden, E., Graham, M., Greenwood, L., Mills, J. G., Popat, A., Truong, L., & Bonomo, Y. A. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211035394 · Cited by 11
The intersection of astrocytes and the endocannabinoid system in the lateral habenula: on the fast-track to novel rapid-acting antidepressants
Arjmand, S., Landau, A. M., Varastehmoradi, B., Andreatini, R., Joca, S. R. L., & Wegener, G. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01598-4 · Cited by 11
How safe are hemp-based food products? A review and risk assessment of analytical data from Germany
Steinmetz, F. P., Nahler, G., & Wakefield, J. C. (2022) · Nutrition & Food Science · doi:10.1108/nfs-04-2022-0129 · Cited by 11
Subtype‐specific modulation of human K V 7 channels by the anticonvulsant cannabidiol through a lipid‐exposed pore‐domain site
Pökl, M., Sridhar, A., Frampton, D. J. A., Linhart, V. A., Delemotte, L., & Liin, S. I. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16183 · Cited by 10
Drug Delivery System Approaches for Rheumatoid Arthritis Treatment: A Review
Garhwal, A., Kendya, P., Soni, S., Kori, S. K., Soni, V., & Kashaw, S. K. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230913105803 · Cited by 10
Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
Sooda, K., Allison, S. J., & Javid, F. A. (2023) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1152 · Cited by 10
Discovery and development of macrocyclic peptide modulators of the cannabinoid 2 receptor
Tomašević, N., Emser, F. S., Muratspahić, E., Gattringer, J., Hasinger, S., Hellinger, R., Keov, P., Felkl, M., Gertsch, J., Becker, C. F. W., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107330 · Cited by 10
New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect
Guldager, M. B., Biojone, C., da Silva, N. R., Godoy, L. D., & Joca, S. R. L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111029 · Cited by 10
The Effect of Phytocannabinoids and Endocannabinoids on Nrf2 Activity in the Central Nervous System and Periphery
Marini, P., Maccarrone, M., Saso, L., & Tucci, P. (2024) · Neurology International · doi:10.3390/neurolint16040057 · Cited by 10
Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats
Brakatselos, C., Polissidis, A., Ntoulas, G., Asprogerakas, M.-Z., Tsarna, O., Vamvaka-Iakovou, A., Nakas, G., Delis, A. D., Tzimas, P., Skaltsounis, A., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01977-1 · Cited by 10
Cannabidiol (CBD) as an emerging nutraceutical ingredient from industrial hemp: regulation, production, extraction, nutraceutical properties, and functionality
Charles, A. P. R., Chen, B., & Rao, J. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2436130 · Cited by 10
Cannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels
Erustes, A. G., Abílio, V. C., Bincoletto, C., Piacentini, M., Pereira, G. J. S., & Smaili, S. S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149414 · Cited by 10
The Pharmacology of Cannabinoids
Copas, G., Amazonas, E. D. A., & Brandon, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-68317-7_2 · Cited by 10
Cannabidiol counters the effects of a dominant-negative pathogenic Kv7.2 variant
Zhan, X., Drummond-Main, C., Greening, D., Yao, J., Chen, S. W. R., Appendino, J. P., Au, P. Y. B., & Turner, R. W. (2022) · iScience · doi:10.1016/j.isci.2022.105092 · Cited by 10
Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients
Christensen, C., Allesø, M., Rose, M., & Cornett, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010307 · Cited by 10
Applications of Capillary Electrophoresis for the Determination of Cannabinoids in Different Matrices
Blebea, N. M., Hancu, G., Vlad, R.-A., & Pricopie, A. (2023) · Molecules · doi:10.3390/molecules28020638 · Cited by 10
The Endocannabinoid System as a Potential Therapeutic Target for HIV-1-Associated Neurocognitive Disorder
Chu, L., Zheng, S., Gu, X., Wu, Y., Yang, J., & Deng, H. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0267 · Cited by 10
Women are taking the hit: Examining the unique consequences of cannabis use across the female lifespan
Gräfe, E. L., Reid, H. M. O., Shkolnikov, I., Conway, K., Kit, A., Acosta, C., & Christie, B. R. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101076 · Cited by 10
An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry
Erridge, S., Leung, O., Holvey, C., Coomber, R., Beri, S., Khan, S. A., Weatherall, M. W., Rucker, J., Platt, M. W., & Sodergren, M. H. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12403 · Cited by 10
Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023
Lewis, M., Baroutian, S., & Hanning, S. M. (2023) · Current Pain and Headache Reports · doi:10.1007/s11916-023-01196-1 · Cited by 10
Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition In Vivo in Rats
Nagao, M., Nakano, Y., Tajima, M., Sugiyama, E., Sato, V. H., Inada, M., & Sato, H. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0098 · Cited by 10
Evidence for 5‐HT1A receptor‐mediated antiallodynic and antihyperalgesic effects of apigenin in mice suffering from mononeuropathy
Wu, J., Li, Y., Li, B., Wang, Y., Cui, W., Zhou, W., & Zhao, X. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15574 · Cited by 10
Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness
Teoh, D. G. K., Smith, T. J., Song, M., & Spirtos, N. M. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_209437 · Cited by 10
Calculated and experimental 1H and 13C NMR assignments for cannabicitran
Wood, J. S., Gordon, W. H., Morgan, J. B., & Williamson, R. T. (2021) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.5224 · Cited by 10
Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study
Köck, P., Lang, E., Trulley, V.-N., Dechent, F., Mercer‐Chalmers‐Bender, K., Frei, P., Huber, C. G., & Borgwardt, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.736822 · Cited by 9
Cannabidiol: metabolism and clinical efficacy in epileptic patients
Dell’Isola, G. B., Verrotti, A., Sciaccaluga, M., Dini, G., Ferrara, P., Parnetti, L., & Costa, C. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2329733 · Cited by 10
Assessment of Clinical Outcomes in Patients With Osteoarthritis: Analysis From the UK Medical Cannabis Registry
Francis, A., Erridge, S., Holvey, C., Coomber, R., Holden, W., Rucker, J., Platt, M. W., & Sodergren, M. H. (2024) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2024.2340076 · Cited by 9
Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice
Pedrazzi, J. F. C., Sales, A. J., Ponciano, R., Ferreira, L. G., Ferreira, F. R., Campos, A. C., Hallak, J. E. C., Zuardi, A. W., Bel, E. A. D., Guimarães, F. S., et al. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173919 · Cited by 10
Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies
Rafailovska, E., Xhemaili, E., Naumovska, Z., Gigopulu, O., Miova, B., Suturkova-Milosevic, L., & Stefkov, G. (2025) · Pharmaceuticals · doi:10.3390/ph18040446 · Cited by 9
Molecular Mechanisms of the Endocannabinoid System with a Focus on Reproductive Physiology and the Cannabinoid Impact on Fertility
Kalak, P., Kupczyk, P., Szumny, A. J., Gębarowski, T., Jasiak, M., Niedźwiedź, А., Niżański, W., & Dzięcioł, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157095 · Cited by 9
Therapeutic Potential for Cannabidiol on Alzheimer’s Disease-Related Neuroinflammation: A Systematic Review and Meta-Analysis
Wu, S., Rajiah, T., & Ali, A. B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411963 · Cited by 9
Effects of Cannabidiol on Social Relating, Anxiety, and Parental Stress in Autistic Children: A Randomized Controlled Crossover Trial
Parrella, N.-F., Hill, A. T., Enticott, P. G., Botha, T., Catchlove, S. J., Downey, L. A., & Ford, T. C. (2025) · Autism Research · doi:10.1002/aur.70159 · Cited by 9
Modern approaches to the development of synthetic cannabinoid receptor probes
Saldaña-Shumaker, S. L., Grenning, A. J., & Cunningham, C. W. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173119 · Cited by 9
Cannabidiol, a Regulator of Intracellular Calcium and Calpain
Jeon, K., Park, S., Bae, W. J., Kim, S. W., Park, H., Kim, S., Kim, T. H., Jeon, S. H., Park, I., Park, H., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0197 · Cited by 9
Subregional Differences in Alcohol Modulation of Central Amygdala Neurocircuitry
Melkumyan, M., & Silberman, Y. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.888345 · Cited by 9
Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
Shade, R. D., Ross, J. A., & Bockstaele, E. J. V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.949361 · Cited by 9
Hair Regrowth with Novel Hemp Extract
Smith, G. L. (2023) · International Journal of Trichology · doi:10.4103/ijt.ijt_34_22 · Cited by 9
Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors
Ibork, H., Idrissi, S. E., Zulu, S. S., Miller, R. G., Hajji, L., Morgan, A. M., Taghzouti, K., & Abboussi, O. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00671-2 · Cited by 9
UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder
Ittiphakorn, P., Erridge, S., Holvey, C., Coomber, R., Rucker, J., & Sodergren, M. H. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12400 · Cited by 9
Cannabidiol Protects against the Reinstatement of Oxycodone-Induced Conditioned Place Preference in Adolescent Male but Not Female Rats: The Role of MOR and CB1R
Socha, J., Grochecki, P., Marszałek‐Grabska, M., Skrok, A., Smaga, I., Słowik, T., Prazmo, W., Kotlinski, R., Filip, M., & Kotlinska, J. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126651 · Cited by 9
The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut
Brown, K. J., Funk, K., Barrientos, A. F., Bailey, A., Shrader, S. H., Feng, W., McClain, C. J., & Song, Z. (2024) · Cells · doi:10.3390/cells13191618 · Cited by 9
Assessing Allosteric Modulation of CB1 at the Receptor and Cellular Levels
Scott, C. E., & Kendall, D. A. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.05.002 · Cited by 10
The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain
Bagher, A. M. (2021) · Journal of Microscopy and Ultrastructure · doi:10.4103/jmau.jmau_97_20 · Cited by 9
Self-citation
Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response
Johnson, C. T., & Bradshaw, H. B. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0181 · Cited by 9
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
Lima, P. A., Berg, B. B., & Castor, M. G. M. E. (2022) · Intestinal Research · doi:10.5217/ir.2021.00160 · Cited by 12
Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico
Rios, F. C. O., Ruiz, I. G. D., & Dumani, E. S. (2022) · Drugs in Context · doi:10.7573/dic.2022-3-2 · Cited by 9
Cannabidiol-Decorated Berberine-Loaded Microemulsions Improve IBS-D Therapy Through Ketogenic Diet-Induced Cannabidiol Receptors Overexpression
Fan, X., Shi, J., Liu, Y., Zhang, M., Lu, M., & Qu, D. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s402871 · Cited by 9
Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade
Gendy, M. N. S., Ibrahim, C., Sloan, M. E., & Foll, B. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_253 · Cited by 10
Chronic oral dosing of cannabidiol and cannabidiolic acid full-spectrum hemp oil extracts has no adverse effects in horses: a pharmacokinetic and safety study
Wang, T. C., Wakshlag, J. J., Jager, M. C., Schwark, W. S., Trottier, N. L., Chevalier, J. M., Pearson, G. B., & Cercone, M. (2025) · American Journal of Veterinary Research · doi:10.2460/ajvr.24.08.0235 · Cited by 8
The development and therapeutic potential of classical and next-generation cannabinoid ligands
Muñoz-Canales, V., Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., & Ortega‐Gutiérrez, S. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108022 · Cited by 8
The dual roles of natural cannabidiol in combating oxidative stress and inflammation: A potential intestinal guardian
Lv, B., He, J., Zhan, S., Jin, K., Lei, X., Cheng, X., Lv, Z., Chen, F., Li, Y., Lu, J., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104051 · Cited by 11
Differential Expression of CB 1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Protein 1a in Labor
Kozakiewicz, M. L., Zhang, J., Leone‐Kabler, S., Yamaleyeva, L. M., McDonald, A. G., Brost, B. C., & Howlett, A. C. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0107 · Cited by 8
The effects of acute Cannabis smoke or Δ9-THC injections on the trial-unique, nonmatching-to-location and five-choice serial reaction time tasks in male Long-Evans rats
Barnard, I. L., Onofrychuk, T. J., Sandini, T. M., McElroy, D. L., Zagzoog, A., Roebuck, A. J., Austin-Scott, F. V. L., Laprairie, R. B., & Howland, J. G. (2022) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2022.107624 · Cited by 8
Self-citation
Putative Activation of Cannabinoid Receptor Type 1 Prevents Brain Oxidative Stress and Inhibits Aggressive-Like Behavior in Zebrafish
Pinheiro, E. F., Cardoso, P. B., Luz, W. L., Assad, N., Santos-Silva, M., Leão, L. K. R., de Moraes, S. A. S., Passos, A. D. C. F., Batista, E. D. J. O., Oliveira, K. R. H. M., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0146 · Cited by 8
Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
Wilson, G., Yang, L., Su, X., Ding, S., Li, L., Yang, Y., Wang, X., Wang, W., Sa, Y., Zhang, Y., et al. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00544-7 · Cited by 8
Promising immunomodulators for management of substance and alcohol use disorders
Acuña, A. M., Park, C., Leyrer‐Jackson, J. M., & Olive, M. F. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2360653 · Cited by 10
Target receptors in diabetic neuropathy: Key insights & implications
Sharma, G., Badruddeen, B., Akhtar, J., Khan, M. I., Ahmad, M., & Neopane, D. (2024) · Biomedical Research and Therapy · doi:10.15419/bmrat.v11i8.914 · Cited by 8
Medicinal Cannabis and the Intestinal Microbiome
Vitetta, L., Nation, T. R., Oldfield, D., & Thomsen, M. (2024) · Pharmaceuticals · doi:10.3390/ph17121702 · Cited by 8
Acceptability of cannabidiol in patients with psychosis
Chesney, E., Lamper, A. D., Lloyd, M., Oliver, D., Hird, E., & McGuire, P. K. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221128445 · Cited by 8
Cannabidiol Prevents the Expression of the Locomotor Sensitization and the Metabolic Changes in the Nucleus Accumbens and Prefrontal Cortex Elicited by the Combined Administration of Cocaine and Caffeine in Rats
Prieto, J. P., López‐Hill, X., Urbanavicius, J., Sánchez, V., Nadal, X., & Scorza, C. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00218-9 · Cited by 8
Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions
Newton, M., & Newton, D. W. (2020) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390320929410 · Cited by 8
Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569
Aderibigbe, A. O., Pandey, P., & Doerksen, R. J. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1873187 · Cited by 8
Cannabidiol Modulates the Motivational and Anxiety-Like Effects of 3,4-Methylenedioxypyrovalerone (MDPV) in Mice
Alegre-Zurano, L., López‐Arnau, R., Luján, M. Á., Camarasa, J., & Valverde, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158304 · Cited by 10
Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
Failing, C., Boehnke, K. F., & Riebschleger, M. P. (2021) · Pediatric Rheumatology · doi:10.1186/s12969-021-00656-5 · Cited by 9
Cannabinoids and the endocannabinoid system in the regulation of cytochrome P450 metabolic activity-a review
Fonseca, C., Zendulka, O., & Juřica, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1599012 · Cited by 7
Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum
Dirik, S., Doyle, M. R., Wood, C. P., Campo, P., Martinez, A. R., Fannon, M. J., Balaguer, M. G., Seely, S., Montoya, B. A., Cook, G. M. R., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02164-6 · Cited by 7
New frontiers in rheumatoid arthritis therapy: From classic DMARDs to biologics and beyond
Vanshika, Gulati, P., Thakur, R., Bala, D., Bajaj, R., Priya, Bansal, C., Dhiman, T., Verma, I., & Pannu, S. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156307 · Cited by 7
Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
Schuster, N. M., Wallace, M. S., Marcotte, T. D., Buse, D. C., Lee, E., Liu, L., & Sexton, M. (2025) · Headache The Journal of Head and Face Pain · doi:10.1111/head.70025 · Cited by 7
Multi-charged nanoemulsion for photodynamic treatment of glioblastoma cell line in 2D and 3D in vitro models
Borges, H. S., Gusmão, L. A., & Tedesco, A. C. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103723 · Cited by 7
Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm – A Randomized Pilot Study
Silkiss, R. Z., Koppinger, J., Truong, T., Gibson, D., & Tyler, C. W. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.8.17 · Cited by 9
Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review
Hurzeler, T. P., Watt, J., Logge, W., Towers, E., Suraev, A. S., Lintzeris, N., Haber, P., & Morley, K. C. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00224-0 · Cited by 7
Hippocampal D1-like dopamine receptor as a novel target for the effect of cannabidiol on extinction and reinstatement of methamphetamine-induced CPP
Farrokhi, A. M., Moshrefi, F., Eskandari, K., Azizbeigi, R., & Haghparast, A. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111025 · Cited by 7
Effects of cannabidiol, with and without ∆9-tetrahydrocannabinol, on anxiety-like behavior following alcohol withdrawal in mice
Melkumyan, M., Annaswamy, V. M., Evans, A. M., Showemimo, O., McCullers, Z., Sun, D., Murphy, T. E., Vrana, K. E., Arnold, A. C., Raup‐Konsavage, W. M., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1375440 · Cited by 7
Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission
Pedrazzi, J. F. C., Silva-Amaral, D., Issy, A. C., Gomes, F. V., Crippa, J. A., Guimarães, F. S., & Bel, E. D. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173879 · Cited by 7
Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action
Alayoubi, M., Henry, B. A., Cahill, C. M., & Cooper, Z. D. (2024) · Drugs · doi:10.1007/s40265-024-02098-1 · Cited by 7
Do the effects of cannabis on the hippocampus and striatum increase risk for psychosis?
Daniju, Y., Bossong, M. G., Brandt, K. R., & Allen, P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.010 · Cited by 7
Synthetic and Natural Derivatives of Cannabidiol
Morales, P., & Jagerovic, N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-61663-2_2 · Cited by 7
The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB2 Receptors
Franco, R., Morales, P., Navarro, G., Jagerovic, N., & Reyes‐Resina, I. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.852631 · Cited by 7
Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis
Dykukha, I., Essner, U., Schreiber, H., Raithel, L. M., & Penner, I. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104173 · Cited by 7
In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution
Cherry, A. L., Wheeler, M. J., Mathisova, K., & Miceli, M. D. (2024) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2024.1294939 · Cited by 7
Interactions of Cannabinoids With Biochemical Substrates
Thomas, B. F. (2017) · Substance Abuse Research and Treatment · doi:10.1177/1178221817711418 · Cited by 7
Evidence from Human Studies for Utilising Cannabinoids for the Treatment of Substance-Use Disorders: A Scoping Review with a Systematic Approach
Gharbi, K. A., Bonomo, Y. A., & Hallinan, C. M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054087 · Cited by 7
Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis
Evans, A. A., Jesus, C. H. A., Martins, L. L., Fukuyama, A. H., Gasparin, A. T., Crippa, J. A. S., Zuardi, A. W., Hallak, J. E. C., Genaro, K., de Castro, C. J., et al. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0242 · Cited by 7

Authors: Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M.
Affiliations: Dalhousie University (CA)
Corresponding author: Denovan‐Wright, E M
ORCID: Laprairie, R B
Bagher, A M
Kelly, M E M
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2015-10
Volume: 172
Issue: 20
Pages: 4790-4805
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1111/bph.13250
PMC: PMC4621983
OpenAlex: W1945751328
Cited by: 1,039
References: 47
Citations by year: 2026: 92 · 2025: 107 · 2024: 107 · 2023: 107 · 2022: 133 · 2021: 150 · 2020: 125 · 2019: 89 · 2018: 54 · 2017: 49 · 2016: 19 · 2015: 6
FWCI: 30.74
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 12 d)
Locations: British Journal of Pharmacology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research (ROP-97185, MOP-97768)
Killam Trusts
Nova Scotia Health Research Foundation
King Abdulaziz University of Saudi Arabia
Huntington Society of Canada
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: cannabidiol, CB1 receptor, negative allosteric modulation, receptor internalization, ERK1/2 phosphorylation, 2-arachidonoylglycerol, delta-9-tetrahydrocannabinol, allosteric modulators, non-competitive antagonism
MeSH terms: Animals, Cannabidiol, Cell Line, Humans, Arrestins, MAP Kinase Signaling System, Receptor, Cannabinoid, CB1, Mice, Phospholipase C beta, HEK293 Cells, Cannabinoid Receptor Modulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks